Interactions between MTHFR C677T-A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population

• Published in: Asian Pacific journal of cancer prevention : APJCP Vol. 13; no. 5; pp. 2199 - 2206
• Main Authors: Wu, Xia-Yu, Ni, Juan, Xu, Wei-Jiang, Zhou, Tao, Wang, Xu
• Format: Journal Article
• Language: English
• Published: Thailand 01.01.2012
• Subjects: Breast Neoplasms - epidemiology; Breast Neoplasms - etiology; Case-Control Studies; China - epidemiology; Female; Folic Acid Deficiency - complications; Folic Acid Deficiency - genetics; Genetic Predisposition to Disease; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2) - genetics; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic - genetics; Polymorphism, Restriction Fragment Length; Prognosis; Risk Factors; China
• ISSN: 1513-7368; 2476-762X
• DOI: 10.7314/APJCP.2012.13.5.2199

Our objective was to evaluate the MTHFR C677T-A1298C polymorphisms in patients with breast cancer and in individuals with no history of cancer, to compare the levels of genetic damage and apoptosis under folic acid (FA) deficiency between patients and controls, and to assess associations with breast cancer. Genetic damage was marked by micronucleated binucleated cells (MNBN) and apoptosis was estimated by cytokinesis-block micronucleus assay (CBMN). PCR-RFLP molecular analysis was carried out. The results showed significant associations between the MTHFR 677TT or the combined MTHFR C677T-A1298C and breast cancer risk (OR=2.51, CI=0.85 to 7.37, p=0.08; OR=4.11, CI=0.78 to 21.8, p<0.001). The MNBN from the combined MTHFR C677T-A1298C was higher and the apoptosis was lower than that of the single variants (p<0.05). At 15 to 60 nmol /L FA, the MNBN in cases with the TTAC genotype was higher than controls (p<0.05), whereas no significant difference in apoptosis was found between the cases and controls after excluding the genetic background. Associations between the combined MTHFR C677T-A1298C polymorphism and breast cancer are possible from this study. A dose of 120 nmol/L FA could enhance apoptosis in cases with MTHFR C677T-A1298C. Breast cancer individuals with the TTAC genotype may be more sensitive to the genotoxic effects of FA deficiency than controls.